
American Innovation Strikes Back: Cancer Vaccine and CAR-T Therapy Show Real Results
American biotech Anixa hits Phase 1 goals with its breast cancer vaccine and shows ovarian cancer patients surviving past 28 months. Real results, real American innovation.